In a review last year into drugs and treatments and States debate in January, HSC acknowledged that the disparity between life changing NICE TA drugs available in Guernsey compared to the NHS had become too great to be justified, with nearly 4000 patients now on sub-optimal treatments. The Guernsey Health Reserve was identified as the funding source. HSC announced last week a delay of at least a year to the implementation of this policy. How do you propose to tackle the pace at which change takes place within the States? Should you be held accountable for delivering on commitments you make individually, as a committee or collectively as the States?